AN2 Therapeutics Inc (ANTX)

1.26 -0.01 (-0.79%) USD  |  NASDAQ  |  Dec 20, 16:00
1.265 0.00 (0.00%) After-Hours: 20:00
More

AN2 Therapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Biomarin Pharmaceutical Inc Upgrade
Arbutus Biopharma Corp Upgrade
GlycoMimetics Inc --
FibroGen Inc Upgrade
Cidara Therapeutics Inc --